LDL-c & PCSK9i in Clinical Cardiology
European experts discuss the importance of targeting LDL-c in patients at increased CV risk and the potential role of PCSK9 inhibition
Episodes 1-1 of 1
- LDL-c & PCSK9i in Clinical CardiologyWhat are the key issues and challenges impacting clinical management with novel therapeutics lowering cholesterol?
